Idorsia eyes layoffs, tees up Tryvio licensing deal to extend cash runwaynews2024-11-27T12:04:22+00:00November 27th, 2024|Endpoints News|
Sarepta, Arrowhead take a big swing on siRNA drugs for rare diseasenews2024-11-26T16:34:16+00:00November 26th, 2024|Endpoints News|
Updated: Roche buys out CAR-T partner Poseida for $1B upfrontnews2024-11-26T11:41:03+00:00November 26th, 2024|Endpoints News|
Cradle Bio raises $73M Series B for protein-making AI softwarenews2024-11-26T08:00:27+00:00November 26th, 2024|Endpoints News|
Gilead buys experimental HIV vaccines from a small Barcelona biotechnews2024-11-25T13:41:20+00:00November 25th, 2024|Endpoints News|
Halozyme withdraws €2B Evotec acquisition proposalnews2024-11-22T15:30:47+00:00November 22nd, 2024|Endpoints News|
Novartis buys Kate Therapeutics in $1.1B deal, eyes more bolt-on M&Anews2024-11-21T11:10:58+00:00November 21st, 2024|Endpoints News|
Kyowa Kirin buys into Kura leukemia treatment rights for $330M+news2024-11-21T03:32:11+00:00November 21st, 2024|Endpoints News|
23andMe inks new research partnership as it winds down internal drug development effortsnews2024-11-20T15:29:08+00:00November 20th, 2024|Endpoints News|
Pfizer partners with two more Flagship biotechs on obesity, cancernews2024-11-20T11:30:45+00:00November 20th, 2024|Endpoints News|
